Dr Mark Sampson
CHIEF MEDICAL OFFICER
pharmaceutical physician
Shield Therapeutics
Switzerland
Biography
Dr. Mark Sampson serves as Chief Medical Officer at Shield Holdings AG and served as its Vice President of Medical Affairs since January 8, 2016. Dr. Sampson joined Shied with more than 25 years of medical practice, pharmaceutical development and commercialisation experience. He has an outstanding pedigree in the development and leadership of Medical Affairs at companies such as SmithKline Beecham, Amgen and Gilead; having been a key member of a number of successful commercialisation projects. He is a highly experienced pharmaceutical physician who combines broad medical knowledge and business acumen, with an impressive record of achievement in Medical Affairs at affiliate, regional and global levels across pharmaceutical, biotech and consumer products. He was a member of the UK Prescription Medicines Code of Practice Appeals Board for 13 years.
Research Interest
medical knowledge and business acumen
